A thoughtless birthday mammogram reminder underscored how the healthcare system ignored my reality of living with metastatic ...

Dr. Hyman B. Muss discusses the unique facets of care that should inform personalized treatment decision-making for older ...

Mary Anderson’s lifelong commitment to innovation, education and advocacy improves the lives of patients and empowers her ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...

Dr. Andrew M. Evens breaks down what it means to be an adolescent or young adult with lymphoma and how treatment differs from ...

I have worked alongside Carmela Cuccurullo, NP.

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...

Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their ...

I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, ...

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...